High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patients - Wikidata - wikimedia - TriplyDB

High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patients

High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patients

http://www.wikidata.org/entity/Q33739290

about

QSOX1 inhibits autophagic flux in breast cancer cells The emerging role of QSOX1 in cancer The autophagy GABARAPL1 gene is epigenetically regulated in breast cancer models Illuminating luminal B: QSOX1 as a subtype-specific biomarker Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow.The Effect of Mammary Extracellular Matrix in Controlling Oral and Mammary Cancer Cells QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas.Microarray Analysis of the Molecular Mechanism Involved in Parkinson's Disease.

P2860

Q24324407-E65AEDF9-3E28-4D4D-962F-C8A077CD258D Q33828308-18780B2C-225F-4E78-9B46-322702B89238 Q35810837-99E6DDCD-035E-4795-B509-93F0BBB6C56E Q36998375-AA030947-EC78-4D5E-8899-4C7157D9C94C Q37710308-506B61A4-0B2F-4B0E-864B-14000DBF81BC Q49648793-6B42B74C-987B-4C9E-8AFD-4877FAD06895 Q51549817-520F214A-49A6-408D-9EC5-7485A12135FD Q54979603-9897E401-2630-4ACF-998D-EAF582FE1CE8

P2860

High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patients

http://www.wikidata.org/entity/Q33739290

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

High expression of QSOX1 reduc ...... ome for breast cancer patients

@ast

High expression of QSOX1 reduc ...... ome for breast cancer patients

@en

type

label

High expression of QSOX1 reduc ...... ome for breast cancer patients

@ast

High expression of QSOX1 reduc ...... ome for breast cancer patients

@en

prefLabel

High expression of QSOX1 reduc ...... ome for breast cancer patients

@ast

High expression of QSOX1 reduc ...... ome for breast cancer patients

@en

P1433

Q33739290-82E122B9-AEBD-4FF1-9582-43237FEAB533

P1476

Q33739290-52173FC4-53AF-4D51-A66B-3874A895C2A4

P2093

Q33739290-1A0857A2-5C57-418E-9088-2BB4282F8EAA

Q33739290-33681D44-698F-4514-8F74-BF1585E57D1B

Q33739290-4E020E0A-3FB7-4152-8D52-9A91E626D9A1

Q33739290-5D3BE36E-8D6F-4717-B9CD-9D711BC8DE3A

Q33739290-5D54905D-596C-47CD-A88A-0AF2BA6CAC01

Q33739290-5E0D242D-2628-43CF-ADAA-332026435FAF

Q33739290-88E5FAB3-A794-48E8-B6DF-CD7502A9466E

Q33739290-9BE7B627-D1B0-490F-8CB2-13658D782FAD

Q33739290-AC92BD55-2F02-44E2-B896-90047747AC58

Q33739290-CE1F5AA2-3DC9-4705-BDF3-D049FC3D0FEE

P2860

Q33739290-005CB131-C80C-441B-8B21-3D0F134A809C

Q33739290-0466AD28-A30E-42F4-BBCC-F6D363037D8D

Q33739290-093C7121-4CEE-4C32-ADB7-CD76A2E2DEAE

Q33739290-2094890E-EAA4-455A-811F-9F2B257AF59A

Q33739290-248B15B2-9996-47E6-9663-7A96144D4FD1

Q33739290-38693693-E281-48E6-81C3-79709CFE192A

Q33739290-486D2969-69DD-42D6-B3D3-1B891BB65FF8

Q33739290-4A55B75A-96C4-4C13-8C73-C98E909AC4BE

Q33739290-566C3364-D4BE-400B-B6DE-CFA8600C7D5D

Q33739290-59D39B91-6330-444A-AF24-72AE31FFE72E

P2888

Q33739290-A017D426-A8A7-455D-A2F7-9DB3858B098E

P304

Q33739290-B11791C5-0013-4E3A-A0A9-F8EB2675F151

P31

Q33739290-7DD6ED0B-E822-4B9C-BB3A-8EE136535E9A

P356

Q33739290-73C30E25-EFFD-4F6F-BD2D-EFFA5F300C45

P433

Q33739290-351F3E3C-5C7B-4739-A328-61A6DC4F1973

P478

Q33739290-FA486B16-0EA1-4DEF-9834-EF5CFFA3AEC8

P577

Q33739290-9FAB8909-FC57-4DB1-B763-15EA0B2C034B

P5875

Q33739290-A4853E71-E32D-4897-AC23-C02A09BEFCCC

P6179

Q33739290-ADEDE7AF-A9D5-48FE-86F0-B5404D305AC9

P698

Q33739290-E33DB8D5-BDCA-4755-93FE-FA53434DFA25

P932

Q33739290-3973796D-27E0-4D67-87E4-A4E2C3F2C415

P356

P1433

Breast Cancer Research

P1476

High expression of QSOX1 reduc ...... ome for breast cancer patients

@en

P2093

Anne Vejux

http://www.w3.org/2001/XMLSchema#string

Christophe Borg

http://www.w3.org/2001/XMLSchema#string

François Hermetet

http://www.w3.org/2001/XMLSchema#string

Françoise Descotes

http://www.w3.org/2001/XMLSchema#string

Frédéric Esnard

http://www.w3.org/2001/XMLSchema#string

Gabriel Viennet

http://www.w3.org/2001/XMLSchema#string

Gilles Despouy

http://www.w3.org/2001/XMLSchema#string

Jean-René Pallandre

http://www.w3.org/2001/XMLSchema#string

Marjorie Adams

http://www.w3.org/2001/XMLSchema#string

Michèle Jouvenot

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of the quiescence-induced genes: quiescin Q6, decorin, and ribosomal protein S29

Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Preferential gene expression in quiescent human lung fibroblasts

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

Sulfhydryl oxidases: emerging catalysts of protein disulfide bond formation in eukaryotes

Rat seminal vesicle FAD-dependent sulfhydryl oxidase. Biochemical characterization and molecular cloning of a member of the new sulfhydryl oxidase/quiescin Q6 gene family.

Mechanism of integrin activation by disulfide bond reduction.

Identification and expression of a new sulfhydryl oxidase SOx-3 during the cell cycle and the estrus cycle in uterine cells.

Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention.

P2888

P304

R136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR3341

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232703893

http://www.w3.org/2001/XMLSchema#string

P6179

1035224121

http://www.w3.org/2001/XMLSchema#string

P698

23098186

http://www.w3.org/2001/XMLSchema#string

P932

4053115

http://www.w3.org/2001/XMLSchema#string